Status:

UNKNOWN

Longitudinal Study of the Intestinal, Cutaneous and Salivary Microbiota in Children With Food-induced Enterocolitis Syndrome (SEIPA)

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

FPIES

Eligibility:

All Genders

Up to 18 years

Brief Summary

Food Protein-Induced Enterocolitis Syndrome (FPIES) is a non IgE-mediated allergy, presenting with vomiting, and may be complicated by hypovolemic shock. The pathophysiology of FPIES is not well char...

Detailed Description

1.1 Current state of knowledge Food Protein- Induced Enterocolitis Syndrome (FPIES) is a food allergy with a prevalence of 0.34% and an incidence of 15.4 children per 100,000 per year. It is a non-IgE...

Eligibility Criteria

Inclusion

  • patients aged from the first days of life to 18 years old
  • confirmed FPIES

Exclusion

  • inflammatory bowel disease
  • long term antibiotics
  • immunodeficiency

Key Trial Info

Start Date :

December 26 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2024

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT04081415

Start Date

December 26 2019

End Date

April 1 2024

Last Update

August 3 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Trousseau Hospital, Service : Nutrition et Gastroentérologie Pédiatrique

Paris, France

Longitudinal Study of the Intestinal, Cutaneous and Salivary Microbiota in Children With Food-induced Enterocolitis Syndrome (SEIPA) | DecenTrialz